Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Al-Shazly Gaber Mohamed Galal"'
Autor:
Al-Shazly Gaber Mohamed Galal, Reham M. Dawood, Mostafa K. El Awady, Yasser Mohamed Mohamed El-Dessouky, Mohamed Mahmoud Abdel-Halim Mahmoud, Mohamed Darwish Ahmed Abd Alla
Publikováno v:
Journal of Genetic Engineering and Biotechnology, Vol 21, Iss 1, Pp 1-8 (2023)
Abstract Background and aims Predictors of chronic HCV response to oral antiviral therapy (OAT) are related to host genetic variations. Single nucleotide polymorphisms (SNP) and alleles variations of host genes in association with hepatic fibro-cirrh
Externí odkaz:
https://doaj.org/article/cf42373330714c04853a0163166be4d5
Autor:
Mohamed Salem Negm, Mostafa Mostafa Kamel El-Awdy, Al-Shazly Gaber Mohamed Galal, Shabaan Salah Al-Azhari
Publikováno v:
The Egyptian Journal of Hospital Medicine. 66:46-51
Background:unlike human immunodeficiency virus (HIV) and hepatitis B virus (HBV), hepatitis C virus (HCV) infection is a curable disease. Current direct acting antiviral agent (DAA) targets are focused on HCV NS3/4A protein (protease), NS5B protein (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0fe68cfbb6adf951355ddbe0baf4bb8c
https://doi.org/10.12816/0034632
https://doi.org/10.12816/0034632
Autor:
Mostafa Abdel Aziz Elhawary, Shabaan Salah Al-Azhari, Mohamed Darwish Ahmed Abd Alla, Reham M. Dawood, Al-Shazly Gaber Mohamed Galal, Mostafa K. El Awady
Publikováno v:
Archives of virology. 163(10)
The disappearance of hepatitis C virus (HCV) from serum and tissues for 12 weeks after the end of treatment (EOT) with direct-acting antivirals (DAAs) is known as a “sustained virologic response” (SVR) and occurs more frequently in non-cirrhotic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25f22bf96a5a47adda7dfaf83525ab16
https://pubmed.ncbi.nlm.nih.gov/29971486
https://pubmed.ncbi.nlm.nih.gov/29971486